Position of the Transparency Council – Citrulline 200, Citrulline 1000, L-Citrulline

At its meeting on 14 October 2024, the Transparency Council adopted position No. 109/2024 on the legitimacy of issuing approvals for reimbursement of foodstuffs for special nutritional use Citrulline 200, Citrulline 1000 and L-Citrulline for the indications: ornithine transcarbamylase deficiency, carbamylphosphate synthase 1 deficiency, lysinuric protein intolerance.

Publication of the position >>